Ray's 'Chair Side CAD Solution' Receives FDA Class II Approval

[Asia Economy Reporter Hyungsoo Park] Ray Co., Ltd. announced on the 20th that its core digital therapy solution, Raydent Designer (Chairside CAD solution), has obtained the US FDA Class II certification.

Ray registered as Class II NOF, the same as the global CAD solution company Exocad Chairside.

The digital therapy solution involves processes such as scanning, designing, manufacturing, and management. Raydent Designer belongs to the design process. Ray expects it to be the most important core technology in digital therapy solutions and a key competitive advantage to surpass competitors.

Raydent Designer supports users to easily manufacture prosthetics within the dental clinic by simply mastering its easy-to-use interface. Users can add desired tooth libraries and perform occlusion adjustments both automatically and manually.

It is possible to design diagnostic wax-ups for implant surgery. STL files can be edited as desired or extracted.

A Ray official stated, "By registering Raydent Designer with the FDA, we can demonstrate that it is of a world-class level," and added, "Ray's advanced technology will be a great foundation for Ray's further significant growth."

Starting as a dental diagnostic equipment specialist company in 2004, Ray launched its digital therapy solution in 2017. It is currently a specialized manufacturer of dental medical devices with a lineup covering everything from dental diagnosis to treatment.

This content was produced with the assistance of AI translation services.